Literature DB >> 3955903

Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control.

J Bergström, A Alvestrand, H Bucht, A Gutierrez.   

Abstract

In 17 patients with chronic renal failure (creatinine clearance 12-66 ml/min) who entered a prospective study, clinical and laboratory check-ups were made once a month. This was much more frequent than during the preceding 2-year period. The progression rate of renal failure evaluated from the change with time in the reciprocal of serum creatinine and creatinine clearance, respectively, was significantly slower after entering the study than before, without any dietary intervention having been instituted. The retardation of progression was associated with improved blood pressure control. We conclude from this study that the frequency and presumably the quality of the clinical check-ups, especially with regard to control of hypertension, may favorably influence the progression of chronic renal failure, independently of the protein intake. This may have important implications for the design of randomized studies, aimed at assessing whether a lowering of protein intake may retard progression.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955903

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  12 in total

Review 1.  Interventions in chronic renal failure.

Authors:  J R Curtis
Journal:  BMJ       Date:  1990-09-29

2.  Can we meet the real need for dialysis and transplantation?

Authors:  A J Wing
Journal:  BMJ       Date:  1990-10-20

Review 3.  Angiotensin-converting enzyme inhibitors in chronic renal failure.

Authors:  J A Opsahl; P A Abraham; W F Keane
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 4.  Do glomerular hemodynamic adaptations influence the progression of human renal disease?

Authors:  A S Woolf; L G Fine
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 5.  Angiotensin converting enzyme (ACE) inhibitors and renal function. A review of the current status.

Authors:  A L Kamper
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

6.  The effects of candesartan on diabetes glomerulopathy: a double-blind, placebo-controlled trial.

Authors:  Nina E S S Perrin; Georg A Jaremko; Ulla B Berg
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

7.  Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease.

Authors:  J A Opsahl; P A Abraham; W F Keane
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

8.  The calcium channel blocker nisoldipine delays progression of chronic renal failure in humans (preliminary communication).

Authors:  H E Eliahou; D Cohen; A Ben-David; D Herzog; I Serban; S Gavendo; S Kapuler; N Kogan; B Hellberg
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

9.  Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and Modification of Diet in Renal Disease equation: an observational, cross-sectional study.

Authors:  Narinder P Singh; Gopal K Ingle; Vinay K Saini; Ajita Jami; Pankaj Beniwal; Madan Lal; Gajender S Meena
Journal:  BMC Nephrol       Date:  2009-02-17       Impact factor: 2.388

Review 10.  Slowing the progression of adult chronic kidney disease: therapeutic advances.

Authors:  Maarten W Taal
Journal:  Drugs       Date:  2004       Impact factor: 11.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.